Biolargo Inc (BLGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,189 | -11,047 | -3,803 | -1,921 | -4,347 |
| Depreciation Amortization | 293 | 375 | 233 | 97 | 255 |
| Accounts receivable | -1,814 | -1,958 | -2,368 | -1,077 | -569 |
| Other Working Capital | -1,135 | -2,086 | -1,803 | -707 | -1,620 |
| Other Operating Activity | 9,548 | 8,009 | 3,793 | 1,778 | 3,075 |
| Operating Cash Flow | $-8,297 | $-6,707 | $-3,948 | $-1,830 | $-3,206 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -46 | -33 | N/A | N/A | -1,235 |
| Other Investing Activity | 481 | 481 | 192 | 0 | -82 |
| Investing Cash Flow | $435 | $448 | $192 | $N/A | $-1,317 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 1,261 | 1,311 | 590 | N/A |
| Debt Issued | 24 | 50 | N/A | N/A | -14 |
| Debt Repayment | N/A | -18 | -9 | -4 | N/A |
| Common Stock Issued | 4,791 | 3,731 | 2,397 | 280 | 3,588 |
| Other Financing Activity | 3,406 | 2,245 | 0 | 0 | 864 |
| Financing Cash Flow | $8,221 | $7,269 | $3,699 | $866 | $4,438 |
| Exchange Rate Effect | -24 | -12 | -20 | -20 | 94 |
| Beginning Cash Position | 3,548 | 3,548 | 3,548 | 3,548 | 3,539 |
| End Cash Position | 3,883 | 4,546 | 3,471 | 2,564 | 3,548 |
| Net Cash Flow | $335 | $998 | $-77 | $-984 | $9 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,297 | -6,707 | -3,948 | -1,830 | -3,206 |
| Capital Expenditure | -46 | -33 | N/A | N/A | -1,235 |
| Free Cash Flow | -8,343 | -6,740 | -3,948 | -1,830 | -4,441 |